Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

3 Months Ended

Mar. 31, 2020

NOTE 4 — SELECTED FINANCIAL STATEMENT CAPTIONS - ASSETS

Inventories consisted of the following (in thousands):

	March 31, 2020			December 31, 2019
Raw materials and components	$	1,409		$	1,187
Work-in-process		1,851			1,629
Finished goods		5,109			5,204
Inventory reserve		(114	)		(49	)
Total	$	8,255		$	7,971

Prepaid expenses and other current assets consisted of the following (in thousands):

	March 31, 2020		December 31, 2019
Prepaid insurance	$	453	$	735
Other prepaid expenses and current assets		649		667
	$	1,102	$	1,402

Property and equipment consisted of the following (in thousands):

	March 31, 2020			December 31, 2019
Equipment	$	338		$	335
Leasehold improvements		39			77
Furniture and fixtures		95			95
Total property and equipment		472			507
Less: accumulated depreciation		(330	)		(356	)
Property and Equipment, net	$	142		$	151

During the three months ended March 31, 2020 and 2019, depreciation expense was approximately $12,000 and $14,000, respectively.